×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions for Rubius Therapeutics, Inc. (RUBY)

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
RUBYRubius Therapeutics, Inc.Appelhans DannielleCEO and PresidentFeb 24, 2023Sale$0.1310,3851,3230Feb 27, 2023, 06:08 PM
RUBYRubius Therapeutics, Inc.CAGNONI PABLO JDirectorFeb 01, 2023Sale$0.258,4482,11266,082Feb 01, 2023, 09:41 PM
RUBYRubius Therapeutics, Inc.Appelhans DannielleCEO and PresidentFeb 01, 2023Sale$0.253,87897010,385Feb 01, 2023, 09:40 PM
RUBYRubius Therapeutics, Inc.CAGNONI PABLO JDirectorJan 31, 2023Sale$0.247,2401,74574,530Jan 31, 2023, 09:51 PM
RUBYRubius Therapeutics, Inc.Turka Laurence A.Chief Scientific OfficerJan 31, 2023Sale$0.242,59362218,391Jan 31, 2023, 09:50 PM
RUBYRubius Therapeutics, Inc.Appelhans DannielleChief Operating OfficerAug 10, 2022Sale$0.805,7374,5906,763Aug 12, 2022, 03:06 PM
RUBYRubius Therapeutics, Inc.Epstein David RDirectorApr 21, 2022Buy$1.4430,00043,3294,720,012Apr 22, 2022, 06:07 PM
RUBYRubius Therapeutics, Inc.CAGNONI PABLO JCEO and PresidentFeb 01, 2022Sale$6.576,73044,23635,520Feb 01, 2022, 09:20 PM
RUBYRubius Therapeutics, Inc.Keson-Brookes MaikenCLO & Corp. SecretaryFeb 01, 2022Sale$6.572,73217,9575,343Feb 01, 2022, 09:19 PM
RUBYRubius Therapeutics, Inc.Turka Laurence A.Chief Scientific OfficerFeb 01, 2022Sale$6.572,51716,5444,921Feb 01, 2022, 09:18 PM
RUBYRubius Therapeutics, Inc.Flagship Ventures Fund V, L.P.10% OwnerMar 19, 2021Buy$29.00210,0006,090,00015,393,593Mar 23, 2021, 05:30 PM
RUBYRubius Therapeutics, Inc.Keson-Brookes MaikenCLO & Corp. SecretaryMar 15, 2021Option Exercise$13.9750,000698,46525,000Mar 15, 2021, 08:28 PM
RUBYRubius Therapeutics, Inc.Epstein David RDirectorFeb 11, 2021Sale$14.9326,704398,5604,690,012Feb 16, 2021, 09:51 PM
RUBYRubius Therapeutics, Inc.Epstein David RDirectorFeb 08, 2021Sale$14.8889,2331,328,1174,726,220Feb 10, 2021, 09:12 PM
RUBYRubius Therapeutics, Inc.Epstein David RDirectorFeb 09, 2021Sale$14.832,10031,1464,724,120Feb 10, 2021, 09:12 PM
RUBYRubius Therapeutics, Inc.Epstein David RDirectorFeb 10, 2021Sale$14.797,404109,5254,716,716Feb 10, 2021, 09:12 PM
RUBYRubius Therapeutics, Inc.OH ANDREW M.Chief Financial OfficerMay 15, 2020Option Exercise$4.745,00023,7005,000May 19, 2020, 08:02 PM
RUBYRubius Therapeutics, Inc.Coughlin Christina M.Chief Medical OfficerApr 22, 2020Buy$5.5219,000104,81319,000Apr 24, 2020, 04:13 PM
RUBYRubius Therapeutics, Inc.CAGNONI PABLO JCEO and PresidentApr 14, 2020Buy$4.7021,00098,69421,000Apr 15, 2020, 05:14 PM
RUBYRubius Therapeutics, Inc.Epstein David RDirectorMar 17, 2020Buy$3.765,00018,8004,815,453Mar 19, 2020, 06:34 PM
RUBYRubius Therapeutics, Inc.Epstein David RDirectorMar 13, 2020Buy$3.9110,00039,1004,810,453Mar 17, 2020, 05:59 PM
RUBYRubius Therapeutics, Inc.CARPENTER CHRISTOPHER L.Chief Medical OfficerDec 16, 2019Sale$8.1796,000784,66182,843Dec 18, 2019, 07:50 PM
RUBYRubius Therapeutics, Inc.LANGER ROBERTDirectorOct 14, 2019Sale$4.3315,00064,9997,500Oct 17, 2019, 06:01 AM
RUBYRubius Therapeutics, Inc.CARPENTER CHRISTOPHER L.Chief Medical OfficerSep 16, 2019Sale$6.5072,246469,57070,966Sep 18, 2019, 09:37 PM
RUBYRubius Therapeutics, Inc.CARPENTER CHRISTOPHER L.Chief Medical OfficerSep 17, 2019Sale$6.4623,754153,39646,720Sep 18, 2019, 09:37 PM
RUBYRubius Therapeutics, Inc.NISSEN TORBEN STRAIGHTPresidentJul 24, 2019Option Exercise$0.18207,14637,6082,052,450Jul 26, 2019, 07:06 PM
RUBYRubius Therapeutics, Inc.LANGER ROBERTDirectorJul 15, 2019Sale$7.5415,000113,1747,500Jul 17, 2019, 04:14 PM
RUBYRubius Therapeutics, Inc.CARPENTER CHRISTOPHER L.Chief Medical OfficerJun 20, 2019Option Exercise$8.404864,08335,086Jun 24, 2019, 06:02 PM
RUBYRubius Therapeutics, Inc.CARPENTER CHRISTOPHER L.Chief Medical OfficerJun 17, 2019Option Exercise$8.4937,000313,96353,343Jun 19, 2019, 09:39 PM
RUBYRubius Therapeutics, Inc.CARPENTER CHRISTOPHER L.Chief Medical OfficerJun 18, 2019Option Exercise$8.5721,716186,12045,701Jun 19, 2019, 09:39 PM
RUBYRubius Therapeutics, Inc.CARPENTER CHRISTOPHER L.Chief Medical OfficerJun 19, 2019Option Exercise$8.3336,798306,67353,242Jun 19, 2019, 09:39 PM
RUBYRubius Therapeutics, Inc.LANGER ROBERTDirectorApr 15, 2019Option Exercise$8.8615,000132,9247,500Apr 17, 2019, 08:42 PM
RUBYRubius Therapeutics, Inc.NISSEN TORBEN STRAIGHTPresidentApr 08, 2019Sale$20.002,10042,0001,845,304Apr 10, 2019, 09:44 PM
RUBYRubius Therapeutics, Inc.NISSEN TORBEN STRAIGHTPresidentApr 03, 2019Sale$20.0050010,0001,859,500Apr 05, 2019, 07:34 PM
RUBYRubius Therapeutics, Inc.NISSEN TORBEN STRAIGHTPresidentApr 05, 2019Sale$20.0012,096241,9201,847,404Apr 05, 2019, 07:34 PM
RUBYRubius Therapeutics, Inc.CARPENTER CHRISTOPHER L.Chief Medical OfficerMar 15, 2019Sale$9.3596,000897,87482,843Mar 19, 2019, 06:17 PM
RUBYRubius Therapeutics, Inc.CARPENTER CHRISTOPHER L.Chief Medical OfficerJan 22, 2019Option Exercise$2.8734,84399,99934,843Jan 24, 2019, 05:24 PM
RUBYRubius Therapeutics, Inc.LANGER ROBERTDirectorJan 14, 2019Sale$7.3715,000110,5697,500Jan 18, 2019, 04:36 PM
RUBYRubius Therapeutics, Inc.Sohn Catherine A.DirectorJul 20, 2018Buy$23.002,50057,5002,500Jul 23, 2018, 04:34 PM
RUBYRubius Therapeutics, Inc.Pomerantz RogerDirectorJul 20, 2018Buy$23.001002,300100Jul 23, 2018, 04:33 PM
RUBYRubius Therapeutics, Inc.Cuss Francis MDirectorJul 20, 2018Buy$23.0010,000230,00010,000Jul 23, 2018, 04:33 PM
RUBYRubius Therapeutics, Inc.Symonds JonathanDirectorJul 20, 2018Buy$23.0025,000575,00025,000Jul 23, 2018, 04:33 PM